GENERIC DRUG MANUFACTURERS
Generic Manufacturers subscribe to IPD Analytics to help identify
ANDA opportunities, accessing in-depth, continuously-updated,
patent, regulatory, and competitive analysis.
PATENT & REGULATORY
Gain a deeper understanding of drug protections and how they change over time with loss-of-exclusivity predictions on thousands of drugs in every major therapeutic category.
Let our litigation projections and
day-by-day coverage keep you up to date on impactful courtroom events, reducing legal costs with real-time updates and analyses on settlements, hearings, oppositions, and
appeals happening around the world.
View the entire competitive landscape from clinical-trial monitoring to loss of exclusivity and beyond, accessing summary data and analysis from hundreds of sources at the drug, company, disease, and technology level.
PAYER & PROVIDER
Understand how payor coverage decisions shape the value of your ANDA, evaluating risks and opportunities within the changing landscape surrounding complex generics, biosimilars, 505(b)(2) NDAs, and rare and orphan diseases.